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Abstract: Topical application of antifungals does not have predictable or well-controlled 
release characteristics and requires reapplication to achieve therapeutic local concentration 
in a reasonable time period. In this article, the efficacy of five different US Food and Drug 
Administration-approved antifungal-loaded (amphotericin B, natamycin, terbinafine, flucon-
azole, and itraconazole) electrospun gelatin fiber mats were compared. Morphological studies 
show that incorporation of polyenes resulted in a two-fold increase in fiber diameter and the 
mats inhibit the growth of yeasts and filamentous fungal pathogens. Terbinafine-loaded mats 
were effective against three filamentous fungal species. Among the two azole antifungals 
compared, the itraconazole-loaded mat was potent against Aspergillus strains. However, 
activity loss was observed for fluconazole-loaded mats against all of the test organisms. The 
polyene-loaded mats displayed rapid candidacidal activities as well. Biophysical and rheologi-
cal measurements indicate strong interactions between polyene antifungals and gelatin matrix. 
As a result, the polyenes stabilized the triple helical conformation of gelatin and the presence 
of gelatin decreased the hemolytic activity of polyenes. The polyene-loaded fiber mats were 
noncytotoxic to primary human corneal and sclera fibroblasts. The reduction of toxicity with 
complete retention of activity of the polyene antifungal-loaded gelatin fiber mats can provide 
new opportunities in the management of superficial skin infections.
Keywords: fungal infections, electrospinning, antifungals, controlled release, drug–matrix 
interactions
Introduction
Pathogens from a large group of fungi and yeasts are increasingly impacting the global 
biota and constitute one of the planet’s biggest killers threatening food security and 
ecosystems.1–3 While superficial fungal infections are the most common form of infec-
tions, affecting 20%–25% of the world’s population,4 the invasive fungal and yeast 
infections associated with excessive use of medical devices and implants and expand-
ing numbers of immunocompromised patients are responsible for increased health 
care costs, morbidity, and mortality.5–7 In addition, new fungal and yeast pathogens 
have emerged that have reduced susceptibility or enhanced resistance to the available 
antifungals.8–10 Compared to antibiotics for treating bacterial infections, only limited 
categories of antifungal drugs are available for fungal infections: the polyene mac-
rolides, azoles, allylamines, fluoropyrimidines, and echinocandins.11,12
Due to warm and humid conditions in tropical countries, superficial and subcu-
taneous fungal infections are relatively common.13 The architecture of the skin pres-
ents a formidable barrier for drug penetration, thus impeding the drug efficacy and 
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local bioavailability.14 Therefore, a high concentration of 
the drug at the site of infection is required to achieve clini-
cal efficacy. A number of strategies such as polymeric and 
peptide hydrogels, nanoparticles, microemulsion,  liposomes, 
niosomes, or ethosomes that can function as drug depots 
for delivering the antifungals at the site of infections have 
been reported.15–20 However, these formulations need to 
be applied frequently to maintain sustained release of the 
drugs.21 Nonwoven fiber mats produced by electrospinning 
have the potential for a wide range of applications such as 
filters, composites, drug carriers, wound dressing, and tissue 
regeneration.22–25 Wound dressings prepared by electrospin-
ning of biopolymers provide several key attributes, such as 
high encapsulation efficiency and sustained delivery of drugs 
for a longer time, that are required for transdermal/topical 
delivery of drugs.26 Electrospun fiber mats carrying  various 
antimicrobial agents, carbon nanotubes, N-halamines, 
 vitamin A, and vitamin E have been reported.27–32 However, 
the in vitro efficacy of antifungal drugs incorporated into 
electrospun fibers against yeasts/filamentous fungi has not 
yet been demonstrated.33
In terms of mechanism of action, the available antifungals 
can be grouped into three categories: 1) polyene, azole, and 
allylamine antifungals that target ergosterol or ergosterol 
biosynthetic pathways; 2) echinocandins, which are β-glucan 
synthase inhibitors; and 3) fluoropyrimidines, which target 
RNA synthesis. Due to its inherent biodegradability under 
physiological environments and nonimmunogenic properties, 
gelatin is used in numerous food and cosmetic applications 
as well as in cell-compatible biomaterials.34,35 Using appro-
priate solvent composition, electrospinning has been used to 
generate gelatin fibers with a wide range of diameters.36 In 
this study, the efficacy of polyene, azole, and allylamine anti-
fungal drugs (Figure 1) incorporated into gelatin fiber mats 
against various yeasts/fungal pathogens were evaluated, their 
fungicidal kinetics were tested, and their toxicity on primary 
fibroblast cells was assessed. The interaction between drugs 
and gelatin was investigated by circular dichroism (CD) and 
rheological studies.
Materials and methods
chemicals and reagents
Gelatin (from porcine skin, high bloom), amphotericin B, 
natamycin, terbinafine hydrochloride, itraconazole, flucon-
azole, and trifluoroethanol were purchased from Sigma-
 Aldrich (St Louis, MO, USA). All chemicals were of 
analytical grade and used without further purification.
electrospinning of antifungal-loaded 
gelatin fiber mats
Antifungal drug-loaded gelatin fiber mats were fabricated by 
the electrospinning method. Gelatin (1 g) was dissolved in 
10 mL of trifluoroethanol at a concentration of 10% weight/
volume (w/v). The drugs were added to the gelatin solution 
so that the final antifungal:gelatin ratio was maintained 
at 0.25 wt%. The mixture was stirred overnight at room 
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Figure 1 chemical structures of antifungals used in this study. (A) amphotericin B; (B) natamycin; (C) fluconazole; (D) itraconazole; (E) terbinafine chloride.
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temperature to achieve a homogenous solution. The over-
night stirred solution was poured into a standard 10 mL 
syringe that was attached to a steel needle. Electrospinning 
was carried out by introducing a high voltage (direct current 
high voltage power  supply; Gamma High Voltage Research, 
Inc., Ormond Beach, FL, USA) to the needle as a positive 
electrode and a fixed sheet of grounded aluminum foil. The 
distance between the needle tip and collector was set at 12 
cm. When the positive electrode reached a critical voltage 
of 12 kV, the spinning head extruded polymer solution and 
the electrospun fibers were deposited on to the aluminum 
foil kept at the collector. The emitting rate of the polymer 
solution was controlled at 0.6 mL/hour by means of a syringe 
pump (KD Scientific Inc., Holliston, MA, USA). The as-spun 
fiber mats were exposed for vapor phase crosslinking of 
glutaraldehyde by placing an aqueous solution of glutaral-
dehyde (50%) in a Petri dish kept beneath the fiber mats in 
a closed desiccator. After glutaraldehyde vapor treatment, 
the sample was vacuum dried for 2 days to remove residual 
glutaraldehyde and solvent. The crosslinking time was 3 
hours and 24 hours for the antifungal-loaded fiber mats and 
control gelatin mats, respectively.
scanning electron microscopy (seM)
The morphology and diameter of the gelatin crosslinked 
electrospun fibers were observed and determined with the use 
of an optical microscope (BX51M; Olympus Corporation, 
Tokyo, Japan) and an SEM (Quanta 200F; FEI, Hillsboro, 
Oregon, USA). Prior to imaging with the use of SEM, a small 
section of the fibers on the sample holder was sputter coated 
with gold (JFC-1200 fine coater; JEOL, Tokyo, Japan). 
SEM was then used to observe the samples at an accelerat-
ing voltage of 10–15 kV. The average diameter of the fibers 
(n=50) was estimated from four SEM images, each from two 
independent experiments.
radial diffusion assay
Fungus and yeast cell cultures (at a concentration of 
0.5 McFarland standards) were spread onto the surface of 
sterile Sabouraud dextrose agar plates using a cotton swab in 
9 cm diameter Petri dishes. The fiber mats (0.5 cm × 0.5 cm) 
and antifungal-loaded gelatin fiber mats were placed on top 
of the swabbed cultures and incubated at 37°C.  Antifungal 
activity of fiber mats was visualized as the diameter of the 
zone of inhibition after incubating plates in the dark for 
48 hours for Candida strains and 72 hours for Fusarium and 
Aspergillus strains. The assay was performed in two indepen-
dent duplicates and the average value was reported.
Kinetics of candidacidal action
To assess the candidacidal properties of the polyene-loaded 
fiber mats, time-kill kinetics against a Candida albicans 
DF 2672R strain was carried out. Cultures were grown 
overnight in Sabouraud dextrose broth and the yeast cell 
concentration was adjusted to 1.5×105 Colony Forming 
Units (CFU)/mL. Fiber mats and antifungal-loaded fiber 
mats (0.5×0.5 cm in triplicates) were incubated with 1 mL of 
the cell suspension in a 24-well Nunc® dish (Thermo Fisher 
Scientific, Waltham, MA, USA) and incubated at 37°C with 
constant shaking. At predetermined time points, 100 µL of 
the suspension was withdrawn, serially diluted (102 or 103 
fold), and poured into a Sabouraud dextrose agar plate. The 
plate was incubated for 48 hours at 37°C for colony counting. 
The data were expressed in terms of percentage of fungal 
survival with respect to the positive control (ie, fiber mats 
without antifungals).
antifungals release properties 
of electrospun fiber mats
The antifungal-loaded fiber mats (n=4) were weighed and 
immersed in 10 mL of phosphate buffered saline (PBS) buffer 
(pH 7.0) with constant shaking at 37°C. A 1 mL aliquot of 
the above solution was withdrawn at various time intervals, 
centrifuged, and the amount of drugs in the supernatant 
was determined by spectrophotometry with the calibration 
method. Each time the mother liquor was reloaded with a 
fresh 1 mL of buffer to maintain the total volume of the 
release solution at 10 mL. The characteristic absorption 
bands of each antifungal were used to estimate the amounts 
of antifungals released. The values were converted into µg 
of antifungals released/10 mg of the fiber mat.
Minimum inhibitory concentration 
(MIc) of antifungals
MIC values for amphotericin B, natamycin, fluconazole, and 
terbinafine chloride were determined in two independent 
duplicates by the microdilution method. Overnight cultivated 
yeast strains were suspended in Sabouraud dextrose broth at a 
starting optical density at 600 nm of ∼0.08 in a flat-bottomed 
microtiter plate. A serial dilution of the antifungals in the 
same broth was mixed with the inoculum to give a final 
peptide concentration of 0.1–128 µg/mL. The antifungal 
activity was assessed by monitoring the optical density at 
600 nm in cycles of 30 minutes and an orbital shaking at 
100 rpm using an Infinite® M200 microplate reader (Tecan 
Group Ltd, Männedorf, Switzerland) for 48 hours at 37°C. 
Cultures without antifungals were used as positive controls 
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and broth alone or with 256 µg/mL of the antifungals served 
as negative controls. The minimum concentration required 
for complete inhibition was assessed by both visible observa-
tions as well as by measuring the optical density at 600 nm 
and taken as the MIC.
cD spectropolarimetry
Far ultraviolet (UV) CD spectra of gelatin (0.1 mg/mL) was 
recorded on a spectropolarimeter (J810; JASCO International 
Co, Ltd, Tokyo, Japan) in 10 mM PBS (pH 7.0) using a 
0.1 cm path length quartz cuvette at 30°C. Spectra were 
recorded from 260 nm to 190 nm (for gelatin) and 450 nm to 
300 nm (for amphotericin B) in 0.1 nm steps at a scan rate of 
50 nm/minute. The final spectrum is the average of four scans. 
For the variable temperature CD experiments, ellipticity at 
224 nm was monitored over a temperature of 10°C–60°C 
at a heating rate of 5°C/minute. To study the influence of 
antifungals on the secondary structure, gelatin was incubated 
with 0.25 wt% antifungals and the CD measurements were 
recorded as before.
Rheological characterization  
of antifungal–gelatin interactions
Rheological experiments were performed at room tem-
perature using a controlled strain rheometer (ARES-G2; 
TA  Instruments, New Castle, DE, USA). The rheometer is 
equipped with two sensitive force transducers for torque rang-
ing from 0.05 mN/m to 200 mN/m. The gel was placed onto 
parallel-plate geometry (25 mm in diameter). The dynamic 
storage modulus (G′) and loss modulus (G″) of the gel were 
examined as a function of frequency from 0.1–100 rad/ second. 
The measurements were carried out at strain amplitude (γ 0) 
of 5% to ensure the linearity of viscoelasticity.
UV spectroscopy of amphotericin B
UV spectra of amphotericin B were recorded on a UV1800 
double beam spectrophotometer (Shimadzu, Kyoto, KYT, 
Japan) at room  temperature. To determine aggregation status 
of amphotericin B, the  spectra were recorded in dimethyl 
sulfoxide (DMSO), 10 mM PBS buffer (pH 7.0), and in the 
presence of gelatin.
hemolytic activity of polyenes  
in the presence of gelatin
Hemolytic activity of polyenes in the presence of gelatin 
was determined against rabbit red blood cells.37 Briefly, 
two independent triplicates of 32 µg/mL and 64 µg/mL of 
 amphotericin B or natamycin in PBS was mixed with rabbit 
red blood cells to a final concentration of 4% volume/volume 
(v/v), incubated at 37°C for 1 hour and centrifuged at 3,000 
rpm for 10 minutes. To study the effect of gelatin–antifungal 
interactions, the drugs were incubated overnight with an 
appropriate amount of gelatin so that the antifungal:gelatin 
ratio was 0.25 wt% and added to the rabbit red blood cells. 
The release of hemoglobin in the supernatant was monitored 
by measuring the hemoglobin absorbance at 576 nm. The 
readings from cell suspension in PBS (without any additives) 
or 1%  Triton-X100 were used as 0% or 100% hemolysis, 
respectively.
cytotoxicity of antifungal- 
loaded fiber mats
Both the antifungal-loaded and bare fiber mats were adhered 
to microscope cover slips (n=4) and plated onto 24-well Nunc 
dishes. Human corneal and sclera fibroblasts were grown in 
HyClone® Dulbecco’s Modified Eagle’s Medium (Thermo 
Fisher) with 10% fetal bovine serum antimycotic solution con-
taining 500 units/mL penicillin G, 0.1 mg/mL streptomycin 
sulfate, and 2.25 µg/mL amphotericin B (Sigma-Aldrich). 
The cells were seeded at a concentration of ∼4×104 cells/well 
and incubated with the fiber mats at 37°C for 24 hours. After 
equilibrating the plates to room temperature, an equal volume 
of CellTiter-Glo® reagent was added (Promega Corporation, 
Madison, WI, USA). The adenosine triphosphate content was 
determined by recording the luminescence on a Tecan Infinity 
M200 plate reader as per the manufacturer’s instruction.
Uniaxial tensile tests
Mechanical properties of electrospun fibrous membranes 
were determined with a tabletop uniaxial testing machine 
(Model 3345; Instron, Norwood, MA, USA) with the use of 
a 10 N load cell under a crosshead speed of 5 mm/minute 
at ambient conditions (25°C and 70% relative humidity). 
All samples were prepared in the form of rectangular shape 
with dimensions of 20×10 mm from the electrospun fibrous 
membranes. The thicknesses of samples were measured 
with a digital micrometer. At least five samples were tested 
for each type of electrospun fiber mats and the average was 
reported.
statistical analysis
For statistical analysis, the data were analyzed by using 
Prism® 6.0 software (GraphPad Software, Inc., La Jolla, CA, 
USA). All the experimental data were expressed as mean ± 
standard deviation. Two-tailed Student’s t-test and one-way 
analysis of variance with Newman–Keuls post hoc analysis 
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were used for determining the significance of differences. 
P,0.05 was considered significant.
Results and discussion
Morphology of antifungal- 
loaded fiber mats
Gelatin and antifungal-loaded gelatin fiber mats were 
 electrospun from trifluoroethanol solution and their anti-
fungal activities were evaluated. After an initial optimiza-
tion, 10% w/v of gelatin was used and the final antifungal 
concentration was maintained at 0.25% weight/weight (w/w) 
in order to minimize bead formation. Figure 2A–F show 
the morphology of gelatin and various antifungal-loaded 
gelatin fibers imaged after glutaraldehyde crosslinking. The 
images show smooth surface and absence of any beading, 
pores, or physical defects in various antifungal loaded fiber 
mats. The average diameters of individual fibers in various 
antifungal-loaded mats are shown in Figure 2G. Fiber mats 
without antifungals had a mean diameter of 0.8±0.4 µm. 
The average diameters of the individual fibers in both the 
polyene antifungal-loaded mats had a larger and broader 
diameter distribution compared to the other antifungal-loaded 
mats (P,0.001). For the two polyene-loaded mats, the aver-
age diameters of the fibers remained higher for natamycin 
(1.8±1.0 µm) compared to amphotericin B (1.4±0.9 µm). For 
electrospun gelatin, an increase in diameter was observed 
with an increasing concentration of gelatin or solvent com-
position.36 In the absence of these parameters, the above 
results indicate significant interactions between the poly-
enes and gelatin matrix. Among the two azoles, addition of 
fluconazole did not affect the diameter distribution of the 
fibers (0.8±0.4 µm), whereas incorporation of itraconazole 
increased the dia meter moderately (1.2±0.6 µm). The aver-
age diameter of terbinafine-loaded fibers (1.4±0.6 µm) was 
larger compared to the control fiber mats.
antifungal properties 
of electrospun fiber mats
The antifungal properties of drug-loaded fiber mats were 
evaluated by radial disc diffusion assay against a panel 
of C. albicans, and the zone of inhibition was measured 
 (Figures S1–S7). Figure 3 shows the activity of antifungal-
loaded fiber mats (expressed as the zone of inhibition) against 
various C. albicans strains. The results suggest that the anti-
fungal activity depends on the type of antifungals loaded. 
Polyene-loaded fiber mats displayed excellent antifungal 
properties, suppressing the growth of both the American 
Type  Culture Collection (Manassas, VA, USA) and the 
clinical isolates of C. albicans (Figure 3A and B). The other 
antifungal-loaded fiber mats displayed significant variability 
in anti-Candida activity. Fluconazole- and terbinafine-loaded 
fiber mats were the least effective as they showed clear 
zone of inhibition against only one strain of C. albicans 
(Figure 3C and D). Itraconazole-loaded fiber mats, on the 
other hand, inhibited the growth of two American Type  Culture 
Collection strains of C. albicans and a weaker  inhibitory 
activity against the other three strains (Figure 3E).
The in vitro antifungal activities of the fiber mats were 
determined against four filamentous pathogens as well. As 
was observed before, both the polyene antifungals inhibited 
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Figure 2 scanning electron micrographs showing the electrospun gelatin 
fibers loaded with various antifungals. (A) No antifungals; (B) amphotericin B; 
(C) natamycin; (D) fluconazole; (E) itraconazole; (F) terbinafine. (G) histogram 
showing the effects of various antifungals on the average fiber diameter.
Notes: ***P,0.001; scale bar =50 µm.
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the growth of all four filamentous fungi (Figure 4A and B). 
Itraconazole-loaded fiber mats showed strong inhibition for 
two Aspergillus strains, whereas fluconazole-loaded fiber 
mats had no activity against all the filamentous pathogens 
tested (Figure 4D and E). Of all the antifungals, terbinafine 
chloride-loaded fiber mats displayed the strongest inhibitory 
activity against filamentous fungal species (Figure 4C). These 
results suggest that polyene-loaded fiber mats retained the 
broad-spectrum antifungal properties, whereas terbinafine 
chloride-loaded fiber mats were effective against filamentous 
fungi. Among the two azoles, itraconazole-loaded fiber mats 
were superior compared to fluconazole-loaded fiber mats.
In vitro release of antifungals from gelatin  
fiber mats and MIC of antifungals
The cumulative release profile for various antifungals was 
determined by UV spectrophotometry (Figure 5). The amount 
of antifungals released is expressed as µg/mg of fiber mats. 
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Figure 3 Efficacy of drug-loaded gelatin fiber mats against yeast strains. The antifungal activity against Candida albicans strains is expressed as the zone of inhibition measured 
by radial diffusion assay. Fiber mats loaded with (A) amphotericin B (*P,0.05 compared to C. albicans aTcc 10231 strains; **P,0.01 compared to C. albicans aTcc 10231 
strains; @@P,0.01 compared to C. albicans aTcc 2091 strains; @@@P,0.001 compared to C. albicans aTcc 2091 strains; #P,0.05 compared to C. albicans aTcc 24433); 
(B) natamycin (*P,0.05 compared to C. albicans aTcc 10231 strains); (C) terbinafine (***P,0.001 compared to all the groups); (D) itraconazole (***P,0.01 compared to all 
the groups except C. albicans aTcc 24433 strains; @@@P,0.001 compared to all the groups except C. albicans aTcc 2091 strains); and (E) fluconazole. ***P,0.001 compared 
to all the groups. (F) Representative photographs showing the zone of inhibition of gelatin (upper panel) and amphotericin B-loaded gelatin (lower panels) fiber mats.
Note: The absence of bars in the graph indicates no inhibition against the particular strain.
Abbreviation: aTcc, american Tissue culture collection.
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Figure 4 Efficacy of drug-loaded gelatin fiber mats against filamentous fungi. The antifungal activity against Aspergillus and Fusarium strains is expressed as the zone of inhibition 
measured by radial diffusion assay. Fiber mats loaded with (A) amphotericin B (***P,0.001 compared to Aspergillus brasiliensis aTcc 16404); (B) natamycin (*P,0.05 
compared to Fusarium solani aTcc 3636 strains; @P,0.05 compared to A. brasiliensis aTcc 16404 strains); (C) terbinafine (***P,0.001 compared to F. solani aTcc 3636 
strains; @@@P,0.001 compared to A. brasiliensis aTcc 16404); (D) itraconazole (***P,0.001 compared to F. solani aTcc 3636 strains; @@@P,0.001 compared to F. solani 
aTcc 26671 strains; #P,0.05 compared to A. fumigatus aTcc 90906 strains); and (E) fluconazole. (F) Representative photographs showing the zone of inhibition of gelatin 
(upper panel) and amphotericin B-loaded gelatin (lower panels) fiber mats.
Note: The absence of bars in the graph indicates no inhibition against the particular strain.
Abbreviation: aTcc, american Tissue culture collection.
The release profile was similar for all the antifungals, 
although the amount of released drugs was different. The 
sustained release of polyene antifungals from fiber mats 
indicated significant drug–gelatin interactions.38 At the end of 
3 days, the amount of amphotericin B and natamycin released 
in the medium was 9.5 µg/mL and 8.5 mg/mL, respectively. 
The amount of terbinafine released was 7.3 µg/mL. Of all 
the antifungals, fluconazole was released in maximum 
amounts (14 µg/mL). To understand the loss of activity for 
other antifungals when incorporated into the gelatin matrix, 
the MIC of all the antifungals alone against five different 
C. albicans strains was determined. Table 1 compares the 
determined MIC of various antifungal agents. Amphotericin 
B displayed the lowest MIC followed by natamycin against 
all the C. albicans strains examined. Interestingly, four 
C. albicans strains showed resistance to fluconazole as the 
MIC was .64 µg/mL. A good correlation was observed 
between the amounts of antifungals released and MIC values 
of free antifungals against particular strains of C. albicans. 
Thus, poor antifungal properties and release characteristics 
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are responsible for apparent loss of activity of azoles and 
terbinafine upon incorporation into the gelatin matrix.
Kinetics of candidacidal action  
of polyene-loaded fiber mats
Since both the polyene-loaded fiber mats displayed generally 
good inhibitory activity, the remaining experiments were 
performed with amphotericin B- and natamycin-loaded fiber 
mats. After incubation for 52 hours, both the polyene-loaded 
fiber mats resulted in considerable loss of viability ($2 log 
reduction in viability) of C. albicans (Figure 6A), suggest-
ing potent candidacidal action. To gain further insights, the 
kinetics of candidacidal action after exposing C. albicans 
(1.5×105 CFU/mL) to amphotericin B- or natamycin-loaded 
fiber mats was also investigated (Figure 6B). At various 
time intervals, the supernatant was diluted (102 or 103 fold), 
plated on Sabouraud dextrose agar, and the number of yeast 
colonies was counted after 48 hours. For both the polyene 
antifungal-loaded fiber mats, a steep decrease in the viability 
of C. albicans was observed during early incubation time. 
After 24 hours of incubation, amphotericin B-loaded fiber 
mats caused 1.6 log
10
 CFU/mL decrease (97.3% killing), 
whereas natamycin caused 1.2 log log
10
 CFU/mL decrease 
(93% killing) in the viability of C. albicans.
The changes in morphology of C. albicans incubated 
with polyene-loaded fiber mats were investigated by SEM. 
C. albicans incubated with gelatin alone had smooth and intact 
surfaces (Figure 7A). However, cells treated with the polyene 
antifungals had extensive surface deformation and leakage of 
some intracellular components (Figure 7B and C). The damage 
caused by antifungals was more noticeable in the amphotericin 
B-loaded fiber mats than in natamycin-loaded fiber mats. These 
results confirm that the polyene-loaded fiber mats retained the 
antifungal activity even in the presence of gelatin.
Interaction of gelatin with antifungals
Since the fiber diameter of gelatin mats was doubled in 
the presence of polyene-loaded antifungals, the interac-
tion between antifungals and gelatin was investigated 
using spectroscopy and rheometry. First, the changes in 
secondary structure of gelatin were monitored by CD 
spectropolarimetry. Figure 8A depicts the changes in the 
secondary structure of the gelatin solution and gelatin upon 
incubation with 0.25 wt% amphotericin B and natamycin. 
The CD spectra of gelatin showed a strong negative trough 
around 197 nm and no broad positive band in the n-π* region 
(Figure 8A).  However, gelatin incubated with natamycin 
and  amphotericin B displayed a strong maximum in the 
n-π* region  (Figure 8A). The positive maximum was more 
pronounced for natamycin compared to amphotericin B. The 
presence of a positive band around 225 nm is a hallmark for 
triple helical structure associated with collagen.39,40 Using 
the equation reported by Fujitsu et al, the relative helical 
content ([C]
rel
) of gelatin in the presence of polyenes was 
estimated.41 Positive or negative (C)
rel
 indicates increased or 
decreased triple helical content, respectively. (C)
rel
 at 10°C for 
amphotericin B- and natamycin-loaded gelatin was 0.8 and 
2.4, respectively, indicating greater stability of triple helix 
structure in the presence of natamycin.
To further confirm these observations, the variable 
temperature CD was recorded by monitoring the change in 
ellipticity at 225 nm. Thermal transition has been used to 
investigate the helix–coil transition in collagen or collagen 
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Figure 5 Cumulative release profile of antifungals form gelatin fiber mats.
Table 1 Minimum inhibitory concentration of antifungals against various strains of Candida albicans
Antifungals Minimum inhibitory concentration in µg/mL against
C. albicans  
ATCC 10231
C. albicans  
ATCC 2091
C. albicans  
ATCC 24433
C. albicans  
DF 2672R
C. albicans 
DF 1976R
ampB 1.25 1.25 1.25 1.25 1.25
Nata 10 5 10 10 10
Terb 16 64 .64 8 16
Fluco .64 .64 16 .128 .128
Abbreviations: ampB, amphotericin B; aTcc, american Type culture collection; C. albicans, Candida albicans; Fluco, fluconazole; Nata, natamycin; Terb, terbinafine chloride.
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mimetic peptides.42,43 For gelatin without antifungals, a linear 
change in ellipticity ([θ]
225
) with temperature was observed 
suggesting denatured conformation and lack of a triple 
helix structure (Figure 8B). However, gelatin incubated with 
natamycin and amphotericin B displayed a nonlinear change 
in ellipticity, indicating clear helix–coil transition (Figure 8B 
and C). As was observed before, natamycin promoted the 
helical conformation more significantly than amphotericin B. 
Sugars and polyols can protect the native structure and pro-
mote helix–coil transition of gelatin by crosslinking through 
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Figure 6 (A) Candidacidal properties of the fiber mats loaded with amphotericin B and natamycin. (B) Kinetics of candidacidal action of amphotericin B and natamycin-
loaded fiber mats.
Notes: There was a significant decrease in the viability of Candida albicans exposed to antifungal-loaded fiber mats; **P,0.01.
Abbreviation: ampB, amphotericin B.
Figure 7 Morphology of Candida albicans grown on polyene-loaded fiber mats. Scanning electron micrographs of C. albicans treated with (A) gelatin fiber mats without 
antifungals; (B) amphotericin B-loaded fiber mats; and (C) natamycin-loaded fiber mats.
Note: Inset scale bar =10 µm.
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hydrogen bonding.41,44 The results suggest that the greater 
stabilization of gelatin by the two polyenes is attributed to a 
significantly higher number of hydroxyl groups present (ten 
in amphotericin B and five in natamycin). However, at this 
stage, it is difficult to conceive the increased triple helical 
propensity in the presence of natamycin over amphotericin B, 
though the latter has a higher number of −OH groups. In the 
presence of terbinafine, a small increase in helical propensity 
was observed, whereas fluconazole had no significant influ-
ence on the secondary structure of gelatin (Figure S8). The 
estimated (C)
rel
 was 0.78 in the presence of terbinafine and 
0.5 for fluconazole-loaded gelatin, thus confirming a weak 
interaction between fluconazole and gelatin.
Rheological studies of the drug-loaded gelatin solutions 
were carried out to determine if the interaction of antifungals 
modified the physical properties of the gels.  Macroscopically, 
a nonflowable gel was obtained with or without drug. This 
material did not flow even when the sample vial was inverted. 
A solid-like behavior was observed with G′ greater than G″ 
under these conditions, and both the moduli were almost inde-
pendent of frequency at higher frequency ranges  (Figures 8D 
and S9). The frequency-independent value of G′ for gelatin 
solution without any antifungals was 767±27 Pa. The G′ value 
was increased to 851±7 Pa and 848±9 Pa in the presence of 
amphotericin B and natamycin, respectively. Combined with 
CD studies, it is likely that the increased association between 
the gelatin chains brought about by the supramolecular inter-
actions between the polyenes and the protein chains through 
hydrogen bonding results in increased storage modulus and 
increased diameter of the fibers. This interesting phenomenon 
certainly warrants further investigation and suggests that 
rheology, along with spectrometry methods, could provide 
valuable information on drug–matrix interactions.
Gelatin stabilizes the monomeric 
forms of amphotericin B
It has been shown that the toxicity of amphotericin B for 
mammalian cells depends on the level of aggregation.45,46 In 
aqueous solutions, amphotericin B exists in an aggregated 
form containing about 2,000 molecules, whereas in DMSO the 
monomeric form is predominant below 5 mM.47 The character-
istic absorption bands in UV and CD spectroscopic methods 
can differentiate between the different states of aggregation. 
Therefore, the UV absorption spectra of  amphotericin B under 
various conditions were recorded. In DMSO, amphotericin B 
displayed four clear characteristic absorption bands around 
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Figure 8 Interaction between polyene antifungals and gelatin probed by circular dichroism spectropolarimetry and rheological studies. (A) Far ultraviolet circular dichroism 
spectropolarimetry of gelatin and gelatin incubated with polyene antifungals at 30°c. Thermal denaturation of gelatin in the presence of (B) amphotericin B and (C) natamycin. 
The concentration of antifungals was 0.25 wt% with respect to gelatin. (D) Frequency sweep of storage modulus (g′) of gelatin and antifungal-loaded gelatin.
Abbreviation: ampB, amphotericin B.
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350, 368, 388, and 412 nm (Figure 9A). In buffer, the intensity 
of well-defined absorption bands decreased and a broad band 
around 340 nm was observed. However, the presence of gelatin 
lowers the extent of aggregation of amphotericin B and all 
four major peaks were visible (Figure 9A). The band around 
412 nm is a measure of monomeric form of amphotericin 
B, whereas the band at 346 nm is assigned to an aggregated 
form.48 The ratio of two peak intensities at 346 nm and 412 nm 
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Figure 9 (A) Ultraviolet absorption spectra of amphotericin B in three different media. The four peaks observed in the monomeric amphotericin B are labelled. The 
concentration of amphotericin used was 50 µg/ml. The Y-axis for the amphotericin B in gelatin is represented separately. (B) The relative aggregation state of amphotericin 
B as measured by the intensity ratio of peak I and peak IV of the absorption spectra in three different media. (C) circular dichroism spectrum of amphotericin B in three 
different media. Note the bisignate nature of amphotericin B in phosphate buffered saline indicating a complex structure. (D) hemolytic activity of amphotericin B and 
natamycin in the presence/absence of gelatin. For all these studies, the antifungal:gelatin ratio was 0.25 wt%. (E) Ultraviolet absorption spectra of amphotericin B released 
from the gelatin matrix. For a comparison, the absorption spectra of free amphotericin B (10 µg/ml) in buffer is also shown.
Note: ***P,0.001.
Abbreviations: ampB, amphotericin B; DMsO, dimethyl sulfate; PBs, phosphate buffered saline; aU, arbitrary unit.
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determines the extent of aggregation of amphotericin B. In 
DMSO, a peak ratio of 0.5 was observed as the concentration 
of amphotericin B was varied from 1–50 µg/mL, indicating 
the presence of monomeric forms (Figure 9B). In buffer, the 
peak ratios were 1.5 at lower and 3.1 at higher concentrations 
of amphotericin B. However, in the presence of gelatin, the 
peak ratio was 0.47 below 20 µg/mL and increased to 0.73 
at 50 µg/mL of amphotericin B, thus confirming that gelatin 
prevents the aggregation of amphotericin B in aqueous solu-
tion (Figure 9B).
To confirm these results further, the CD spectra of 
amphotericin B in DMSO, PBS buffer, and in the presence 
of gelatin were also monitored (Figure 9C). Amphotericin B 
displayed three positive bands at 412, 390, and 364 nm which 
are characteristic of conjugated systems.47 In PBS, a bisignate 
shape was observed suggesting supramolecular structure 
of amphotericin B in aqueous solutions. A strong negative 
trough around 346 nm and an intense positive peak around 
320 nm were observed in PBS. However, in the presence 
of gelatin, the spectrum was closer to the one observed in 
DMSO and no intense peak around 320 nm was observed.47 
Based on UV absorption and CD studies, it was concluded 
that the amphotericin B interacts with gelatin in the mono-
meric/oligomeric form and in turn promotes the triple helical 
conformation.
hemolytic activity of antifungal- 
loaded gelatin
Since, in its aggregated form, amphotericin B forms ion 
channels in cholesterol-containing membrane, the hemo-
lytic activity of polyene drugs in the presence of gelatin 
was assessed.49,50 As shown in Figure 9D, the interaction of 
amphotericin B with gelatin resulted in a significant decrease 
in the hemolysis of rabbit erythrocytes compared to free 
drug at 32 µg/mL and 64 µg/mL. Similarly, interaction of 
natamycin with gelatin also resulted in decreased  hemolysis at 
64 µg/mL. These results suggest that the interaction between 
polyene drugs and gelatin is complementary, leading to 
increased triple helical propensity of gelatin and stabilization 
of amphotericin B in monomeric/oligomeric forms which 
otherwise tend to form higher order aggregates in aqueous 
buffers. The stabilization of monomeric/oligomeric forms of 
amphotericin B accounts for the decreased hemolytic  activity. 
Furthermore, controlled release studies from crosslinked 
gelatin fiber mats further confirmed that the released ampho-
tericin B displayed four distinct peaks that are characteristic 
of monomeric forms (Figure 9E).
cytotoxicity of antifungal-loaded  
gelatin fiber mats
The biocompatibility of polyene-loaded antifungals was 
evaluated by monitoring the cell viability of human corneal 
fibroblasts and human sclera fibroblasts primary cells. For a 
comparison we have also determined the cytotoxicity of free 
polyenes with human corneal fibroblast cells (Figure 10A). 
At 10 µg/mL, both natamycin and amphotericin B did 
not show significant cytotoxicity to the human corneal 
fibroblasts. Gelatin gels without glutaraldehyde crosslinking 
also did not show any toxicity. However, 24-hour glutaral-
dehyde crosslinked gelatin fiber mats displayed significant 
toxicity. Natamycin-loaded fiber mats displayed better 
compatibility with the human corneal fibroblasts (∼90% 
viable cells) compared to amphotericin B-loaded fiber mats 
(∼67% viable cells). However, for primary human sclera 
fibroblasts, both the antifungal-loaded fiber mats were 
equally less toxic (∼70% viable cells; Figure 10B). These 
results indicate excellent biocompatibility of fiber mats with 
human fibroblasts.
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Figure 10 Cytotoxicity of polyene-loaded antifungal fiber mats against (A) human corneal and (B) human sclera fibroblasts. XL-gelatin fiber mat is the gelatin crosslinked 
with glutaraldehyde for 24 hours. For amphotericin B- and natamycin-loaded fiber mats the crosslinking time was 3 hours.
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Abbreviation: ampB, amphotericin B.
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Mechanical properties  
of polyene-loaded fiber mats
The mechanical properties of polyene-loaded fiber mats were 
evaluated (Figure 11) and compared with uncrosslinked and 
crosslinked gelatin mats (Table 2). Mechanical strength 
measurements showed a slight increase in Young’s modu-
lus of antifungal-loaded gelatin compared to uncrosslinked 
gelatin. For natamycin-loaded fiber mats, the ultimate tensile 
stress and the ultimate tensile strain decreased compared to 
uncrosslinked gelatin fiber mats. However, amphotericin 
B-loaded fiber mats had improved tensile strain, although 
a slight decrease in the ultimate tensile stress was observed 
compared to the uncrosslinked gelatin fiber mats. When 
compared to crosslinked gelatin fibers, the antifungal-loaded 
fibers had improved elasticity, an important requirement for 
wound dressing.33
Conclusion
In this work, the in vitro efficacy and toxicity of various US 
Food and Drug Administration-approved antifungal-loaded 
electrospun fiber mats were compared. Of the three classes 
of antifungals that were compared, the polyene-loaded fiber 
mats displayed excellent antifungal activities against a wide 
range of pathogenic yeasts and fungi, including filamentous 
Aspergillus spp. and Fusarium spp. The polyene-loaded fiber 
mats resulted in a significant reduction in the viability of 
C. albicans as well as rapid candidacidal action. Conversely, 
the polyene-loaded fiber mats did not decrease the viability 
corneal and sclera fibroblasts, suggesting excellent selectiv-
ity and biocompatibility. Using various spectroscopic and 
rheological measurements, it was demonstrated that polyene 
antifungals interact with a gelatin matrix, which decreases 
the hemolytic activity without significantly altering the 
antifungal activity. These characteristics of polyene-loaded 
fiber mats would be suitable for the management of super-
ficial fungal infections of the skin and the cornea. The poor 
release characteristics and weak antifungal properties are 
responsible for the complete loss of activity of fluconazole-
loaded fiber mats. Antimicrobial nanofibers have been real-
ized as promising scaffolds in many areas such as controlled 
drug delivery, wound dressing, tissue engineering, stem cell 
regeneration and differentiation, and food packaging.38,51–53 
Hydrogel systems, in particular, are potentially advanta-
geous for these applications.54–58 To the best of the authors’ 
knowledge, this is the first report that compares the in vitro 
efficacy of various antifungal-loaded fiber mats and examines 
their physicochemical interactions with gelatin.
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Table 2 Mechanical properties of polyene-loaded fiber mats
Fiber mats Young’s  
modulus  
(MPa)
Ultimate  
tensile stress  
(MPa)
Ultimate  
tensile  
strain (%)
gelatin (not crosslinked) 25.7 1.9 5.5
gelatin (crosslinked  
with glutaraldehyde for 
24 hours)
92.4 2.9 2.9
amphotericin B–gelatin  
(crosslinked with  
glutaraldehyde for 3 hours)
31.5±0.9 1.6±0.3 9.6±1.4
Natamycin–gelatin  
(crosslinked with  
glutaraldehyde for 3 hours)
29.3±0.9 1.5±0.2 3.7±1.1
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Supplementary material
Activity of antifungal-loaded fiber mats and circular dichroism and rheological studies of gelatin–antifungal interactions.
C. albicans 10231 C. albicans 2091
C. albicans 1976RC. albicans 2672R
C. albicans 24433
F. solani 26671
F. solani 3636 A. fumigatus 90906 A. brasiliensis 16404
Figure S1 growth of yeast/fungal pathogens on sabouraud dextrose agar plate.
Abbreviations: C. albicans, Candida albicans; F. solani, Fusarium solani; A. brasiliensis, Aspergillus brasiliensis; A. fumigatus, Aspergillus fumigatus.
C. albicans 10231 C. albicans 2091
C. albicans 1976RC. albicans 2672R
C. albicans 24433
F. solani 26671
F. solani 3636 A. fumigatus 90906 A. brasiliensis 16404
Figure S2 Growth of yeast/fungal pathogens on gelatin fiber mats (without any antifungals).
Abbreviations: C. albicans, Candida albicans; F. solani, Fusarium solani; A. brasiliensis, Aspergillus brasiliensis; A. fumigatus, Aspergillus fumigatus.
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C. albicans 10231 C. albicans 2091
C. albicans 1976RC. albicans 2672R
C. albicans 24433
F. solani 26671
F. solani 3636 A. fumigatus 90906 A. brasiliensis 16404
Figure S3 Antifungal properties of amphotericin B-loaded electrospun fiber mats.
Abbreviations: C. albicans, Candida albicans; F. solani, Fusarium solani; A. brasiliensis, Aspergillus brasiliensis; A. fumigatus, Aspergillus fumigatus.
C. albicans 10231 C. albicans 2091
C. albicans 1976RC. albicans 2672R
C. albicans 24433
F. solani 26671
F. solani 3636 A. fumigatus 90906 A. brasiliensis 16404
Figure S4 Antifungal properties of natamycin-loaded electrospun fiber mats.
Abbreviations: C. albicans, Candida albicans; F. solani, Fusarium solani; A. brasiliensis, Aspergillus brasiliensis; A. fumigatus, Aspergillus fumigatus.
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C. albicans 10231 C. albicans 2091
C. albicans 1976R
C. albicans 2672R
C. albicans 24433
F. solani 26671
F. solani 3636 A. fumigatus 90906 A. brasiliensis 16404
Figure S5 Antifungal properties of fluconazole-loaded electrospun fiber mats.
Abbreviations: C. albicans, Candida albicans; F. solani, Fusarium solani; A. brasiliensis, Aspergillus brasiliensis; A. fumigatus, Aspergillus fumigatus.
C. albicans 10231 C. albicans 2091
C. albicans 1976RC. albicans 2672R
C. albicans 24433
F. solani 26671
F. solani 3636 A. fumigatus 90906 A. brasiliensis 16404
Figure S6 Antifungal properties of itraconazole-loaded electrospun fiber mats. In some strains of C. albicans a weak inhibition was observed.
Abbreviations: C. albicans, Candida albicans; F. solani, Fusarium solani; A. brasiliensis, Aspergillus brasiliensis; A. fumigatus, Aspergillus fumigatus.
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C. albicans 10231 C. albicans 2091
C. albicans 1976RC. albicans 2672R
C. albicans 24433
F. solani 26671
F. solani 3636 A. fumigatus 90906 A. brasiliensis 16404
Figure S7 Antifungal properties of terbinafine-loaded electrospun fiber mats.
Abbreviations: C. albicans, Candida albicans; F. solani, Fusarium solani; A. brasiliensis, Aspergillus brasiliensis; A. fumigatus, Aspergillus fumigatus.
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Figure S8 (A) Far ultraviolet circular dichroism spectropolarimetry of gelatin and gelatin incubated with fluconazole and terbinafine at 30°c. Thermal denaturation of gelatin 
monitored by changes in (θ)225 in the presence of (B) fluconazole and (C) terbinafine. The concentration of antifungals was 0.25 wt% with respect to gelatin.
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Figure S9 Frequency sweep showing the effect of polyenes on loss modulus (g″).
Abbreviation: ampB, amphotericin B.
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